Trevicta 350 is a long-acting injectable antipsychotic medication that contains the active ingredient paliperidone palmitate. It is administered once every 3 months by intramuscular injection.
Active ingredients: Paliperidone palmitate
Dosage form: Injectable suspension
Type of dosage: Long-acting
Mechanism of action: Paliperidone is a long-acting atypical antipsychotic medication that works by blocking dopamine D2 receptors in the brain. Dopamine is a neurotransmitter that is involved in regulating mood, thought, and behavior. By blocking dopamine D2 receptors, paliperidone can help to reduce the symptoms of schizophrenia, such as delusions, hallucinations, and disorganized thinking.
Uses: Trevicta 350 is used for the maintenance treatment of schizophrenia in adults. It is not used to treat acute episodes of schizophrenia.
How to use: Trevicta 350 should be injected once every 3 months by a healthcare professional. It should be injected slowly, deep into the deltoid or gluteal muscle.
Important safety information:
Trevicta 350 can cause serious side effects, including tardive dyskinesia (a movement disorder that can be permanent), neuroleptic malignant syndrome (a rare but life-threatening condition), and cardiovascular problems.
Trevicta 350 should not be used in people with a history of hypersensitivity to paliperidone or any other component of the medication.
Trevicta 350 should be used with caution in people with certain medical conditions, such as heart disease, diabetes, and seizures.
Trevicta 350 can interact with other medications, including antidepressants, anticonvulsants, and lithium. It is important to tell your healthcare professional about all of the medications you are taking before starting Trevicta 350.
How to get started:
If you are interested in trying Trevicta 350, talk to your healthcare professional. They can discuss your individual needs and risks to determine if Trevicta 350 is right for you.
ENGLISH KEYWORDS